Lumenis, the inventor of intense pulsed light (IPL), presents the first and only FDA-approved and TGA-listed IPL for the management of dry eye disease due to meibomian gland dysfunction.
OptiLight elevates dry eye management with Lumenis’ patented Optimal Pulse Technology and user-centered design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLight.
Visit: lumenis.com.au
